SAB Biotherapeutics to Present at the BIO CEO & Investor ConferenceGlobe Newswire • 3 months agoSIOUX FALLS, S.D., Feb. 23, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), ( SAB or the Company ), a clinical-stage biopharmaceutical company with a novel immunotherapy...